Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
royalties
Pharma
Theravance sells remaining Trelegy royalties to GSK for $225M
Theravance estimates that its lifetime earnings from GSK's inhaler Trelegy total $1.52 billion.
Zoey Becker
Jun 2, 2025 9:18am
In royalty dispute, UK appeals court sides with GSK over AZ
Feb 14, 2024 8:22am
Royalty Pharma strikes $150M Skytrofa royalty deal with Ascendis
Sep 6, 2023 11:28am
Arbitration win over J&J gives Alkermes a $425M boost
Jun 6, 2023 3:23pm
After Hemgenix approvals, uniQure inks $400M sale of royalties
May 15, 2023 3:10pm
AZ wins royalties case against GSK over PARP inhibitor Zejula
Apr 5, 2023 7:11pm
